These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25691619)

  • 1. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.
    Li H; Kem DC; Zhang L; Huang B; Liles C; Benbrook A; Gali H; Veitla V; Scherlag BJ; Cunningham MW; Yu X
    Hypertension; 2015 Apr; 65(4):793-9. PubMed ID: 25691619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
    Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
    Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.
    Kem DC; Li H; Velarde-Miranda C; Liles C; Vanderlinde-Wood M; Galloway A; Khan M; Zillner C; Benbrook A; Rao V; Gomez-Sanchez CE; Cunningham MW; Yu X
    J Clin Endocrinol Metab; 2014 May; 99(5):1790-7. PubMed ID: 24552217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism.
    Li H; Yu X; Cicala MV; Mantero F; Benbrook A; Veitla V; Cunningham MW; Kem DC
    J Am Soc Hypertens; 2015 Jan; 9(1):15-20. PubMed ID: 25537460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.
    Li H; Zhang L; Huang B; Veitla V; Scherlag BJ; Cunningham MW; Aston CE; Kem DC; Yu X
    J Interv Card Electrophysiol; 2015 Dec; 44(3):205-12. PubMed ID: 26446828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
    Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
    Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
    J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction.
    Zhang S; Zheng R; Yang L; Zhang X; Zuo L; Yang X; Bai K; Song L; Tian J; Yang J; Liu H
    J Cell Physiol; 2013 Jan; 228(1):142-8. PubMed ID: 22566240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.
    Hong K; Li M; Nourian Z; Meininger GA; Hill MA
    Hypertension; 2017 Dec; 70(6):1264-1272. PubMed ID: 29061726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH receptor-activating autoantibodies in polycystic ovary syndrome: identification of functional epitopes and development of epitope mimetic inhibitors.
    Li H; Guo Y; Deng J; Gali H; Weedin EA; Burks HR; Craig LB; Yu X
    Endocrine; 2022 Mar; 75(3):959-963. PubMed ID: 34807394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism.
    Williams TA; Jaquin D; Burrello J; Philippe A; Yang Y; Rank P; Nirschl N; Sturm L; Hübener C; Dragun D; Bidlingmaier M; Beuschlein F; Reincke M
    Hypertension; 2019 Oct; 74(4):784-792. PubMed ID: 31476909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers.
    Singh KD; Jara ZP; Harford T; Saha PP; Pardhi TR; Desnoyer R; Karnik SS
    Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34380734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
    Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
    J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of losartan on produce of sera autoantibodies to angiotensin II-1 receptor in renovascular hypertension rats].
    Zhi JM; Liu ZB; Jiao XY; Liu YX; Zhao RR
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Feb; 19(1):43-6. PubMed ID: 21207854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of agonistic angiotensin II type I receptor autoantibody-amplified contractile response to Ang II in the isolated rat thoracic aorta.
    Zhang W; Zheng Y; Liu F; Wang X; Jin Z; Zhi J
    Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):851-6. PubMed ID: 26350097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.
    You D; Loufrani L; Baron C; Levy BI; Widdop RE; Henrion D
    Circulation; 2005 Mar; 111(8):1006-11. PubMed ID: 15710752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
    Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
    Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.